Skip to main content
Top

Breast Cancer Research

Issue 3/2002

Content (10 Articles)

Commentary

Hormonal control of p53 and chemoprevention

D Joseph Jerry, Lisa M Minter, Klaus A Becker, Anneke C Blackburn

Open Access Research article

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

Christos Sotiriou, Trevor J Powles, Mitch Dowsett, Amir A Jazaeri, Andrew L Feldman, Laura Assersohn, Chandramouli Gadisetti, Steven K Libutti, Edison T Liu

Open Access Research article

Genetic determinants of mammographic density

Christopher A Haiman, Leslie Bernstein, David Van Den Berg, Sue A Ingles, Martine Salane, Giske Ursin

Open Access Research article

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

Sigurdur Ingvarsson, Bjarnveig I Sigbjornsdottir, Chen Huiping, Sigridur H Hafsteinsdottir, Gisli Ragnarsson, Rosa B Barkardottir, Adalgeir Arason, Valgardur Egilsson, Jon TH Bergthorsson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine